Abstract
participate in its spatial localization. We examined the effects of changes in the distribution of mitochondria on NMDAinduced Ca 2+ increases. Hippocampal cultures were treated with the microtubule-destabilizing agent vinblastine, which caused the mitochondria to aggregate and migrate towards one side of the neuron. This treatment did not appear to decrease the energy status of mitochondria, as indicated by a normal membrane potential and pH gradient across the inner membrane. Moreover, electron microscopy showed that vinblastine treatment altered the distribution but not the ultrastructure of mitochondria. Mitochondria have a large capacity to take up Ca 2+ from the cytoplasm (Gunter and Gunter 2001; Thayer et al. 2002) . Consequently, they act as buffers to shape transient changes in the intracellular Ca 2+ concentration ([Ca 2+ ] i ). In neurons, mitochondria blunt the amplitude and prolong the duration of [Ca 2+ ] i responses evoked by activation of voltage-gated (Friel and Tsien 1994; Werth and Thayer 1994; Babcock et al. 1997 ) and ligand-gated (White and Reynolds 1995; Wang and Thayer 1996; Dedov and Roufogalis 2000) Ca 2+ channels. Increases in the mitochondrial Ca 2+ concentration ([Ca 2+ ] mt ) activate mitochondrial dehydrogenases, coupling the increased metabolic demands indicated by the increase in [Ca 2+ ] i to increased ATP production (McCormack et al. 1990) . When excessive, a raised [Ca 2+ ] mt contributes to opening the permeability transition pore, an early event in both apoptotic and necrotic cell death (Nicholls and Budd 2000) . Isolated mitochondria accumulate Ca 2+ when [Ca 2+ ] i rises above a set point in the range of 0.3-1 lM (Nicholls and Scott 1980) , so this organelle contributes preferentially to shaping [Ca 2+ ] i when exposed to large increases in [Ca 2+ ] i . [Ca 2+ ] i can reach 200-300 lM near the mouths of Ca 2+ channels (Llinas et al. 1992) . Mitochondria near open Ca 2+ channels in the endoplasmic reticulum (Rizzuto et al. 1993) and plasmalemma (Pivovarova et al. 1999; Montero et al. 2000) take up more Ca 2+ than mitochondria distributed throughout the cytoplasm. Thus, proximity to a Ca 2+ source may influence mitochondrial Ca 2+ uptake. Mitochondria are localized within the cytoplasm by the microtubule system (Yaffe 1999) . A number of microtubule-based proteins maintain the cellular distribution of mitochondria, and mutation of these molecules invariably causes mitochondria to redistribute, either to cluster near the nucleus or to aggregate along one side of the cell (Nangaku et al. 1994; Smirnova et al. 1998) . Drugs that destabilize microtubules also cause mitochondria to migrate toward the nucleus (Heggeness et al. 1978) .
We tested the hypothesis that mitochondria near the plasmalemma preferentially take up NMDA-induced Ca 2+ loads. The distribution of mitochondria was altered by treatment with the microtubule inhibitor vinblastine, which caused mitochondria to pull away from the plasmalemma and form aggregates. Mitochondrial function and ultrastructure appeared normal following the brief vinblastine treatment protocol used in this study. Following the redistribution of mitochondria, NMDA-evoked increases in [Ca 2+ ] i were enhanced and evoked increases in [Ca 2+ ] mt were inhibited. These results are consistent with the hypothesis that a subset of mitochondria near a Ca 2+ source preferentially takes up Ca 2+ and they imply location-dependent roles for mitochondria as sources of ATP, Ca 2+ buffers and targets for Ca 2+ -induced toxicity.
Materials and methods

Materials
Coelenterazine f, tetramethylrhodamine ethyl ester (TMRE) and indo-5F acetoxymethyl ester were purchased from Molecular Probes (Eugene, OR, USA). cis-4-Phosphonomethyl-2-piperidine carboxylic acid (CGS19755) was obtained from Research Biochemical International (Natic, MA, USA). Culture media were purchased from Gibco (Grand Island, NY, USA). All other reagents were purchased from Sigma Chemical Company (St Louis, MO, USA).
Cell culture
Primary cultures of rat hippocampal neurons were prepared as described previously (Wang and Thayer 1996) . Fetuses were removed on embryonic day 17 from maternal rats anesthetized with CO 2 and killed by decapitation. Hippocampi were dissected and placed in Ca 2+ -and Mg 2+ -free HEPES-buffered Hanks' salt solution (HHSS), pH 7.45. HHSS contained 20 mM HEPES, 137 mM NaCl, 1.3 mM CaCl 2 , 0.4 mM MgSO 4 , 0.5 mM MgCl 2 , 5.0 mM KCl, 0.4 mM KH 2 PO 4 , 0.6 mM Na 2 HPO 4 , 3.0 mM NaHCO 3 and 5.6 mM glucose. Cells were dissociated by trituration through a 5-mL pipette and then a flame-narrowed Pasteur pipette. Cells were pelleted and resuspended in Dulbecco's modified Eagle's medium (DMEM) without glutamine, supplemented with 10% fetal bovine serum (Sigma) and penicillin/ streptomycin (100 U/mL and 100 lg/mL respectively). Dissociated cells were then plated at a density of 50 000 cells per well on to 25-mm round coverglasses (#1) that had been coated with poly-D-lysine (0.1 mg/mL) and washed with H 2 O. The neurons were grown in a humidified atmosphere of 10% CO 2 )90% air, pH 7.4, at 37°C, and fed every 7 days by exchange of 75% of the media with DMEM supplemented with 10% horse serum (Gibco) and penicillin/streptomycin. Cells were used after 11 days in culture.
Expression of mitochondrially targeted fluorescent proteins
Enhanced green fluorescent protein (EGFP) (pEGFP-C1) and mitochondrially targeted enhanced yellow fluorescent protein (mtEYFP) (pEYFP-mito) constructs were purchased from Clontech (Palo Alto, CA, USA). A plasmid (pEGFP-mito) that targeted EGFP to the mitochondrion (mtEGFP) was constructed by fusing the mitochondrial targeting sequence of cytochrome c oxidase subunit VIII to the 5¢ end of the EGFP-N1 gene as described previously (Rizzuto et al. 1995; Lakshmipathy and Campbell 1999) . All expression vectors used in this study contained the cytomegalovirus promoter. Hippocampal neurons were transfected with plasmid DNA using the calcium phosphate procedure described by Xia et al. (1996) , with some modifications. Briefly, 11-14 days after seeding, hippocampal neurons were transferred into serum-free DMEM (2 mL per well, sixwell plate) supplemented with 1 mM sodium kyneurate, 10 mM MgCl 2 and 5 mM HEPES, pH 7.5, for 15 min. The conditioned medium was saved. A DNA/calcium phosphate precipitate for one six-well plate was prepared by mixing 500 lL 250 mM CaCl 2 and 15 lL plasmid DNA (about 1 lg/lL) with an equal volume of 2 · HEPES-buffered salt solution (274 mM NaCl, 10 mM KCl, 1.4 mM Na 2 HPO4, 15 mM D-glucose, 42 mM HEPES, pH 7.07). The precipitate was allowed to form for 25-30 min at room temperature (22°C) before addition to the cultures. One hundred and twenty-five microliters of the DNA/calcium phosphate precipitate were added dropwise to each well and mixed gently. Plates were then returned to the 10% CO 2 incubator. After 20-25 min the incubation was stopped by washing cells three times with 3 mL DMEM per well. The saved conditioned medium was added back to each well, and the cells were returned to a 10% CO 2 incubator at 37°C. The number of transfected neurons ranged from seven to 64 per coverslip with a mean of 25 ± 15 (results of five experiments performed on five platings).
Confocal microscopy
After 24-48 h, transfected neurons were removed from growth media, transferred to a chamber containing HHSS, and viewed through a 60 · objective. Neurons were imaged with an Olympus Fluoview 300 laser scanning confocal microscope (Melville, NY, USA). Optimal images were obtained by averaging four scans using Kalman filtering. The excitation and emission wavelengths for EGFP were 488 nm, and 522 nm (16nm bandpass), respectively. After completion of each experiment, the microscope stage was adjusted so that no cells or debris occupied the field of view defined by the diaphragm, and the background light levels were determined (typically < 5% of cell counts). Autofluorescence from cells that were not loaded with dye was undetectable. Records were later corrected for background and converted to [Ca 2+ ] i by the equation (Cobbold and Lee 1991; Rizzuto et al. 1993; Padua et al. 1998) . The apo-aequorin gene fused to the mitochondrial targeting sequence from subunit VIII of cytochrome c oxidase (COXVIII) was excised from plasmid mtAeqpMT2 (Rizzuto et al. 1993) . The gene was inserted into shuttle plasmid pAdRSV4 behind the Rous Sarcoma Virus promoter (Bohn et al. 1999) . The Gene Transfer Vector Core at the University of Iowa then incorporated the RSVmtAeq expression cassette into a recombinant adenovirus. After 11-15 days in culture, hippocampal neurons were infected with adenovirus carrying the mitochondrial apo-aequorin expression construct by adding 0.3 · 10 10 )1 · 10 10 viral particles to each culture well in 1.5 mL medium and incubated at 37°C. After 24 h, the infection medium was removed and the cells were returned to their original growth medium for 18-24 h. The apo-aequorin protein was reconstituted to form aequorin by incubating transfected cells in serum-free DMEM containing 5 lM coelenterazine f at 37°C for 1-1.5 h before the experiment. The custom-built luminescence detection system employed here has been described previously (Padua et al. 1998) . After the apoaequorin protein had been reconstituted to aequorin, a coverslip with attached neurons was mounted in a stainless steel perfusion chamber and raised to within 10 mm of an inverted photomultiplier tube (Thorn Instruments Rockaway, NJ, USA). The cells were superfused with HHSS for at least 10 min before starting the experiment to wash out any excess coelenterazine. Luminescence was quantified with a Thorn EMI CT 1 counting board installed in a microcomputer sampling at 1 Hz.
Upon binding Ca 2+ , aequorin emits a photon and its coelenterazine prosthetic group is oxidized, rendering the aequorin incapable of further luminescent reactions with Ca 2+ . Thus, increasing Ca 2+ levels will increase the rate of aequorin decay. To correct for the consumption of aequorin, neurons were lysed at the end of the experiment in the presence of 12.6 mM Ca 2+ in order to discharge any remaining aequorin. Total aequorin counts available during the experiment were determined by integrating photon counts over the entire experiment including lysis. This enabled calculating the fractional rate of aequorin decay (a) from the equation 
Intramitochondrial pH measurement
Mitochondrial matrix pH was measured in cells expressing pH-sensitive mtEYFP. Acidification of the mitochondrial matrix decreased mtEYFP fluorescence (Llopis et al. 1998) . mtEYFP fluorescence images [excitation 480(40) nm, emission 535(50) nm] were projected on to a cooled charge-coupled device camera controlled by a computer using Imaging Workbench software (Axon Instruments, Foster City, CA, USA). Images were collected every 10 s and the exposure to excitation light was < 50 ms per image.
Measurement of mitochondrial membrane potential
Hippocampal neurons were incubated with 100 nM TMRE for the last 30 min of a 2-3-h treatment with either vehicle or vinblastine (1 lg/mL) (Schinder et al. 1996) . TMRE is a cationic fluorescent dye that distributes across membranes in a voltage-dependent manner. Neurons were imaged with an Olympus Fluoview 300 confocal laser scanning microscope using a HeNe laser to excite at 543 nm; emission was detected at > 605 nm. Four scans from a single x-y plane were averaged using Kalman filtering. Membrane potential was calculated from the ratio of the fluorescent intensity from mitochondria (F mt ) relative to cytoplasmic fluorescence (Delcamp et al. 1998) . As there are no mitochondria in the nucleus, nuclear fluorescence (F nuc ) was taken to represent free dye in the cytoplasm. Fluorescent intensities from five to 10 mitochondrial and three nuclear regions were averaged from each cell and converted to membrane potential using the Nernst equation:
Electron microscopy Electron microscopy of cultured hippocampal neurons was carried out using a protocol described by Withers and Banker (1998) with some modifications. Briefly, cells grown on coverslips were fixed with 3.5% glutaraldehyde in culture media for 2 h, rinsed with 0.1 M phosphate buffer, and postfixed in 1% OsO 4 for 30 min. Cells were then rinsed with distilled H 2 O, and stained in 5% aqueous uranyl acetate for 1 h. After washing with distilled H 2 O, cells were dehydrated with successive concentrations of ethanol, then embedded in Epon resin. Ultrathin sections were cut and poststained with 4% uranyl acetate for 20 min followed by modified Reynold's lead stain for 3 min. Sections were examined in a JOEL 1200 EX electron microscope (Peabody, MA, USA).
Statistical analysis
Data are presented as Mean ± S.E.M. Statistical comparisons were made by Student's t-test.
Results
Disruption of the microtubule system alters mitochondrial localization Mitochondria were visualized in live hippocampal neurons in culture using confocal imaging of mitochondrially targeted EGFP (mtEGFP). Extensive vermiform structures were distributed throughout the cytoplasm, consistent with previously reported mitochondrial morphology ( Fig. 1a ) (Rizzuto et al. 1998) . The nucleoplasm, the nuclear envelope and the plasmalemma were devoid of fluorescence. Discrete, individual mitochondria were seen in neuronal processes. Owing to the high density of mitochondria within the soma we could not determine whether the fluorescence represented a syncytial organelle of an extended reticular network or many intermingled individual mitochondria. We next altered the distribution of mitochondria by treating the cells with the microtubule inhibitor vinblastine. Treatment of hippocampal neurons with 1 lg/mL vinblastine for 2-3 h caused mitochondria to aggregate (Fig. 1b) . The initial widely distributed fluorescence seen before drug treatment (Fig. 1a) changed to sites of intense signal, often adjacent to the nucleus, with other regions of the cell completely devoid of fluorescence. A rounding of the soma was observed after 2-3 h of treatment with vinblastine in some cells, an effect that became pronounced after 24 h. These observations are consistent with vinblastine disrupting the microtubule system, resulting in the redistribution of mitochondria. Mitochondrial aggregation, defined by the presence of aggregated masses within the soma and the absence of discrete vermiform structures, was seen in 81 ± 16% of neurons treated with vinblastine for 2-3 h (n ¼ 8 coverslips for a total of 177 transfected cells).
[Ca
2+
] i regulation is altered in vinblastine-treated cells NMDA-induced [Ca 2+ ] i responses were examined in untreated cells and cells with altered mitochondrial distribution. Cells were transfected with pEGFP-mito and 24-48 h later treated with either vinblastine (1 lg/mL) or vehicle for 2-3 h. Cells were loaded with the low-affinity Ca 2+ indicator Indo-5F acetoxymethyl ester during the last 30-45 min of treatment.
The distribution of mitochondria was confirmed to be normal before making recordings from untreated cells (see Fig. 1a ). For vinblastine-treated cultures, recordings were made only from cells with aggregated mitochondria (see Fig. 1b ). Basal [Ca 2+ ] i levels were raised slightly in vinblastine-treated cells (158 ± 16 nM; n ¼ 27) relative to levels in untreated cells (127 ± 10 nM; n ¼ 26) (p < 0.05) (Fig. 2) . Stimulation with 200 lM NMDA (1 min) elicited a significantly greater [Ca 2+ ] i increase in vinblastine-treated (3779 ± 265 nM; n ¼ 11) than untreated cells (2047 ±129 nM; n ¼ 10) (p < 0.0001) (Fig. 2) . These data are consistent with the idea that movement of mitochondria away from the source of Ca 2+ influx at the plasma membrane reduces mitochondrial exposure to high [Ca 2+ ] i near the mouth of plasmalemma Ca 2+ channels resulting in a reduction in Ca 2+ uptake. If reduced mitochondrial Ca 2+ uptake is responsible for the increased amplitude of the NMDA-induced [Ca 2+ ] i response in vinblastine-treated cells, then [Ca 2+ ] mt should be reduced in these cells. We measured [Ca 2+ ] mt directly using the Ca 2+ -sensitive photoprotein aequorin targeted to the mitochondrion. The mitochondrially targeted apo-aequorin gene was transferred to hippocampal neurons using an adenoviral vector as described previously (Wang and Thayer 2002) . The NMDA-induced intramitochondrial Ca 2+ response was significantly smaller in vinblastine-treated cells (0.35 ± 0.03 -log a; n ¼ 7) than that in untreated cells (0.65 ± 0.04 -log a; n ¼ 6) (p < 0.01) (Fig. 3) Vinblastine alters the distribution but not the function or ultrastructure of mitochondria Prolonged exposure (24 h) to 1 lg/mL vinblastine is toxic to hippocampal neurons. It was therefore important to determine the effects of the 2-3-h treatment used here on mitochondrial structure and function. Several lines of evidence suggested that mitochondrial function was not impaired following a 2-3-h exposure to vinblastine. Respiring mitochondria maintain a proton gradient across the inner membrane. We therefore determined the effects of vinblastine on matrix pH and the membrane potential across the inner mitochondrial membrane.
In order to assess the effect of vinblastine on matrix pH we expressed mtEYFP, which fluoresces more strongly at alkaline than at neutral pH (Llopis et al. 1998) (Fig. 4a) . Vinblastine-treated cells displayed aggregated fluorescence (Fig. 4b) . However, both untreated and vinblastine-treated cells showed a comparable degree of quenching produced by the protonophore carbonyl cyanide p-trifluomethoxy phenyl hydrazone (FCCP), which dissipates the mitochondrial pH gradient (Figs 4c and d) . Exposure to 10 lM FCCP for 3 min decreased mtEYFP fluorescence by 11 ± 1% (n ¼ 12) (Fig. 4c ) in untreated neurons and by 10 ± 1% (n ¼ 11) (Fig. 4d ) in vinblastine-treated cells (Fig. 4e) (p > 0.05).
We measured mitochondrial membrane potential with the cationic fluorescent dye TMRE, which distributes across membranes in a voltage-dependent manner (Nicholls and Ward 2000) . Confocal images of untreated and vinblastinetreated cells in the presence of 100 nM TMRE are shown in Figs 5(a) and (b) respectively. Strong TMRE fluorescence was detected as worm-like structures in untreated cells and as aggregates in vinblastine-treated cells. We calculated the membrane potential from the ratio of the fluorescence intensity from the presumed mitochondrial structures to the intensity of the nucleus that is void of mitochondria. Mitochondrial membrane potentials calculated from the Nernst equation were )129 ± 7 mV for untreated and )137 ± 12 mV for vinblastine-treated cells (Fig. 5c ). TMRE accumulation into mitochondria was dependent on mitochondrial membrane potential as indicated by the loss of signal after treatment with the mitochondrial uncoupling agent FCCP (data not shown).
Protein import into the mitochondrion requires an electrochemical gradient across the inner membrane (Schatz and Dobberstein 1996) . We treated hippocampal neurons with vinblastine (1 lg/mL, 2-3 h) before transfection with pEGFP-mito. Fluorescence labeling was detected within subcellular structures in these cells 24-48 h later, indicating that sufficient membrane potential was maintained to enable protein import (n ¼ 4 coverslips; data not shown).
To ascertain whether vinblastine produced structural injury to mitochondria in hippocampal neurons we examined the ] mt . The culture was treated with either vehicle (0.1% DMSO; untreated) or 1 lg/mL vinblastine for 2-3 h before recording. Apo-aequorin was reconstituted with its cofactor coelenterazine f 1 h before recording. [Ca 2+ ] mt was recorded from a population of cells expressing mitochondrially targeted aequorin using a flow-through luminometer (Padua et al. 1998) . [Ca 2+ ] mt is expressed as -log a which is proportional to log [Ca Vinblastine does not affect the pH gradient across the mitochondrial inner membrane. Hippocampal neurons were transfected with pEYFP-mito and 24-48 h later treated with either vehicle or 1 lg/mL vinblastine for 2-3 h. Cells with normally distributed mitochondria (untreated) and aggregated mitochondria (vinblastine) were identified, and fluorescence intensity quantified using digital imaging. Fluorescence intensities were normalized to initial intensity (before FCCP treatment), and plotted against time. FCCP (10 lM) and oligomycin (oligo; 1 lM) were applied at the times indicated by the horizontal bars. Bar graph summarizes data from 11-12 cells recorded from at least three cell cultures.
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ultrastructure of mitochondria in vinblastine-treated cells using electron microscopy. Figure 6 shows electron micrographs from untreated and vinblastine-treated cells; mitochondria in both cells had structurally intact inner and outer membranes with well defined cristae. Consistent with our confocal observations (Fig. 1) , mitochondria in untreated hippocampal neurons were distributed throughout the cytoplasm whereas those in vinblastine-treated cells were aggregated on one side of the cell (bottom right side in Fig. 6b ) leaving other parts of the cell almost completely devoid of mitochondria. Scattered bundles of microtubules were seen in vinblastine-treated cells, but not in control cells, confirming that these cells had been affected by the vinblastine (Muller et al. 1988) . In summary, vinblastine appears to alter the distribution of mitochondria without significantly affecting mitochondrial energy status or structure.
Specificity of vinblastine effects on neuronal Ca
2+ homeostasis
To further address the specificity of the vinblastine effect to the mitochondrially mediated component of Ca 2+ homeostasis we examined additional Ca 2+ -regulated responses in vinblastine-treated cells. Small action potential-induced increases in [Ca 2+ ] i recover by a mono-exponential process that is predominantly dependent on the plasma membrane Ca 2+ -ATPase (PMCA) (Werth et al. 1996; Usachev et al. 2002) . [Ca 2+ ] i recovery following a brief train of action potentials (1 s, 10 Hz) was similar in untreated (s ¼ 3.3 ± 0.2 s; n ¼ 7) and vinblastine-treated (s ¼ 2.9 ± 0.2 s; n ¼ 5) hippocampal neurons (Figs 7a and c) . These data suggest that vinblastine treatment did not deprive the PMCA of ATP nor did drug-induced swelling alter the function of the plasmalemmal Ca 2+ pump. We also examined the effects of vinblastine on responses evoked by 10 lM NMDA. In contrast to the large increase in Ca 2+ evoked by 200 lM NMDA, the response to a low concentration was minimally affected by mitochondrial Ca 2+ uptake (Wang and Thayer 2002) . Thus, the peak amplitude of the response evoked by 10 lM NMDA is predominantly determined by Ca 2+ influx. As shown in Figs 7(b) and (d), treatment with vinblastine did not affect the amplitude of the response elicited by 10 lM NMDA. The peak [Ca 2+ ] i increase was 673 ± 51 nM (n ¼ 21) in untreated and 688 ± 85 nM (n ¼ 14) in vinblastine-treated cells. These data suggest that Ca 2+ influx pathways activated by NMDA are not affected by vinblastine treatment.
To determine the role of endoplasmic reticulum Ca 2+ stores on the NMDA response, we compared the amplitude of responses evoked by 200 lM NMDA in the absence and presence of 5 lM cyclopiazonic acid (CPA) (Fig. 8a) . CPA inhibits sarcoplasmic and endoplasmic reticulum Ca 2+ -ATPases (SERCAs), and so inhibits Ca 2+ uptake into the endoplasmic reticulum and allows stored Ca 2+ to leak into the cytoplasm. Application of CPA produced a small, transient increase in [Ca 2+ ] i (89 ± 7 nM; n ¼ 27) consistent with depletion of Ca 2+ stores (recording not shown). CPA increased the amplitude of the NMDA-evoked response in control cells to a peak [Ca 2+ ] i of 2884 ± 375 nM (n ¼ 14), consistent with the loss of SERCA-mediated Ca 2+ uptake. The amplitude of the NMDA-evoked response in cells treated with vinblastine and CPA was 4198 ± 577 nM (n ¼ 15), a significant increase above that seen in cells treated with CPA alone (p < 0.05). Because treatment with CPA did not occlude the enhancement produced by treatment with vinblastine, we conclude that the increase in the amplitude of the NMDA-evoked response was primarily due to effects on mitochondria rather than endoplasmic reticulum.
The microtubule-stabilizing agent paclitaxel has been reported to open the mitochondrial permeability transition pore (Kidd et al. 2002) . Although vinblastine, the microtubule-destabilizing agent used here, would be predicted to have an opposite effect, if any, we thought it prudent to address this issue. The paclitaxel-induced opening of the permeability transition pore was blocked by 5 lM cyclosporine A (Kidd et al. 2002) . As shown in Fig. 8(b) , pretreatment with 5 lM cyclosporine for 10 min increased the amplitude of the NMDA-evoked response in control cells to a peak [Ca 2+ ] i of 2710 ± 457 nM (n ¼ 13). This increase in amplitude probably results from increased Ca 2+ influx via the NMDA receptor owing to cyclosporine A-dependent relief from the tonic inhibition of the NMDA receptor by the phosphatase calcineurin (Lieberman and Mody 1994) . The amplitude of the NMDA-evoked response in cells treated with vinblastine and cyclosporine A was 4475 ± 767 nM (n ¼ 15), a significant increase above that seen in cells treated with cyclosporine A alone (p < 0.05). As treatment with cyclosporine A did not prevent the enhancement produced by treatment with vinblastine, we conclude that the increase in the amplitude of the NMDA-evoked response was not due to an effect of vinblastine on the permeability transition pore. This observation is also consistent with our electron microscopic results, which showed that the mitochondrial ultrastructure was not altered by treatment with vinblastine. (Llinas et al. 1992) , large increases in [Ca 2+ ] mt in a subset of mitochondria (Montero et al. 2000) , and electron probe microanalysis showing that mitochondrial Ca 2+ deposits formed a radial spread (Pivovarova et al. 1999) .
We (Werth et al. 1996; Usachev et al. 2002) . Thus, these data also support our contention that treatment with vinblastine does not affect the ATP/ADP ratio. Disruption of microtubules might affect the endoplasmic reticulum; however, preventing Ca 2+ uptake into the endoplasmic reticulum did not prevent the increase in the amplitude of the [Ca 2+ ] i response evoked by 200 lM NMDA in vinblastine-treated cells. In summary, the increased amplitude of the [Ca 2+ ] i increase evoked by 200 lM NMDA most probably results from altered mitochondrial Ca 2+ buffering. Interpretation of this study is complicated by the possibility that mitochondrial function was impaired by vinblastine treatment, raising the concern that the increased amplitude of the NMDA-evoked [Ca 2+ ] i response results from the reduced potential for mitochondria to take up Ca 2+ as opposed to their redistribution. Several lines of evidence suggest that mitochondrial function was not impaired. Direct measurement of the mitochondrial membrane potential with TMRE revealed physiological voltages across the inner membrane that were similar for untreated and vinblastine-treated cells. Other mitochondrial functions that require an electrochemical gradient across the inner mitochondrial membrane were also normal, including ultrastructure, the pH gradient and the ability to import cytoplasmic proteins. Additionally, there is precedent in the literature for maintained function of mitochondria following redistribution. Herpes virus infection results in migration of mitochondria towards the nucleus; these perinuclear mitochondria maintained their membrane potential for at least 6 h (Murata et al. 2000) . However, there are also reports that altering the cytoskeleton will affect mitochondrial function (Rappaport et al. 1998) . Of particular relevance to this study are reports that mitochondrial association with microtubules affects the opening of the permeability transition pore. This was shown most clearly for the microtubule-stabilizing agent paclitaxel, which held the permeability transition pore in the open state (Kidd et al. 2002) . In our experiments with hippocampal neurons we did not observe a large increase in basal [Ca 2+ ] i , as was seen when paclitaxel was applied to pancreatic acinar cells (Kidd et al. 2002) , suggesting that microtubule-stabilizing agents have more significant effects on the permeability transition pore than microtubule-destabilizing agents. Colchicine also affected the permeability phase transition at high concentrations (Evtodienko et al. 1996) . The failure of cyclosporine A, which inhibits opening of the permeability transition pore, to inhibit the increase in the NMDA-induced [Ca 2+ ] i response produced by treatment with vinblastine suggests that the permeability transition pore was not opened by either the NMDA stimulus or the vinblastine treatment used in this study. The normal mitochondrial ultrastructure and matrix pH gradient observed in cells treated with 1 lg/mL vinblastine for 2 h are also consistent with the suggestion that this concentration and duration of treatment did not affect the permeability transition pore.
Vinblastine and other vinca alkaloids are anti-cancer drugs that arrest cell proliferation by inhibiting the mitotic spindle apparatus. Neurotoxicity is a major and often dose-limiting side-effect of vincristine and vindesine, and to a lesser extent of vinblastine. The mechanism by which these agents cause neurotoxicity is not fully understood. Previous studies have focused on inhibition of neurite outgrowth and axonal transport (Muller et al. 1988; Geldof et al. 1998) . This study suggests that impaired Ca 2+ buffering might also contribute to neurotoxicity produced by vinca alkaloids.
In Alzheimer's disease and other tauopathy-related neurodegenerative diseases, tau mutations lead to the formation of neurofibrillary tangles that accumulate in the cytoplasm, destabilize microtubules and disrupt the organization of cellular organelles, including mitochondria (Goedert 1993; Hardy and Gwinn-Hardy 1998) . Changes in the distribution of mitochondria may increase vulnerability to insults, such as glutamate neurotoxicity, ischemia and aging. Alternatively, if excessive Ca 2+ uptake into mitochondria opens the permeability transition pore leading to cytochrome c release and activation of the apoptotic cascade (Petronilli et al. 2001 (Bading et al. 1993; Ghosh and Greenberg 1995) . Indeed, Ca 2+ entry via NMDA-gated channels is toxic whereas comparable Ca 2+ loads entering via voltage-gated Ca 2+ channels are not (Sattler et al. 1999) . Activation of extrasynaptic NMDA receptors depolarizes mitochondria and triggers cell death (Hardingham et al. 2002) . This source specificity of Ca 2+ signaling is dependent upon the precise arrangement of intracellular Ca 2+ -sensing targets such as mitochondria. Because altering the distribution of mitochondria altered the [Ca 2+ ] i response, we speculate that the converse is also true, namely that mitochondria alter the spatial profile of Ca 2+ signals. Mitochondrial Ca
2+
buffering modulates a number of local signaling events, including catecholamine secretion from chromaffin cells (Montero et al. 2000) , hormone release from gonadotropes (Kaftan et al. 2000) , short-term plasticity at the crayfish neuromuscular junction (Tang and Zucker 1997) , inactivation of voltage-gated and store-operated Ca 2+ channels (Budd and Nicholls 1996; Hoth et al. 2000) , and release and refilling of Ca 2+ stores (Hajnoczky et al. 1999; Lewis 2001) . Furthermore, these processes all require energy, which could best be met by enhanced ATP production by local mitochondria sensing the Ca 2+ stimulus, an idea consistent with the high concentration of mitochondria in cellular regions of highenergy demand (Hollenbeck 1996 
